Stenotrophomonas maltophilia (Hugh) Palleroni and Bradbury
商品貨號
B230425
Strain Designations
AA
Isolation
Blood - human
Salt Lake City Utah, United States
isolation date: 1993
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Preceptrol®
no
Type Strain
no
Antibiotic Resistance
Resistant to ceftazidime
Medium
ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37.0°C
Atmosphere: Aerobic
Name of Depositor
MW Garrison
Special Collection
NCRR Contract
Chain of Custody
ATCC <<--MW Garrison<<--Associated Regional University Pathologists
Year of Origin
1993
References
Garrison MW, et al. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob. Agents Chemother. 40: 2859-2864, 1996. PubMed: 9124855
blood from a bone marrow transplant recipient after 6 weeks of ceftazidime therapy, Salt Lake City
